Chapter 101
Glycobiology of the Nervous System
Ronald L. Schnaar,
Ronald L. Schnaar
Search for more papers by this authorRonald L. Schnaar,
Ronald L. Schnaar
Search for more papers by this authorProf. Dr. Beat Ernst,
Prof. Dr. Gerald W. Hart,
Prof. Dr. Pierre Sinaý,
Prof. Dr. Beat Ernst
Institut für Molekulare Pharmazie, Universität Basel, Klingenbergstrasse 50, 4051 Basel, Switzerland
Search for more papers by this authorProf. Dr. Gerald W. Hart
Dept. of Biological Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolf St. Rm., 401 Hunterian Baltimore, MD 21205-2185, USA
Search for more papers by this authorProf. Dr. Pierre Sinaý
Dept. de Chimie, URA 1686, Ecole Normale Supérieure, 24 rue Lhomond, 75231 Paris Cedex 05, France
Search for more papers by this authorBook Author(s):Prof. Dr. Beat Ernst,
Prof. Dr. Gerald W. Hart,
Prof. Dr. Pierre Sinaý,
Prof. Dr. Beat Ernst
Institut für Molekulare Pharmazie, Universität Basel, Klingenbergstrasse 50, 4051 Basel, Switzerland
Search for more papers by this authorProf. Dr. Gerald W. Hart
Dept. of Biological Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolf St. Rm., 401 Hunterian Baltimore, MD 21205-2185, USA
Search for more papers by this authorProf. Dr. Pierre Sinaý
Dept. de Chimie, URA 1686, Ecole Normale Supérieure, 24 rue Lhomond, 75231 Paris Cedex 05, France
Search for more papers by this authorSummary
The prelims comprise:
-
Introduction
-
Nervous System Glycoconjugates-Overview
-
Nervous System Glycolipids
-
Nervous System Glycoproteins
-
Lectins in the Brain
-
Concluding Remarks
References
- R. U. Margolis, R. K. Margolis, Eds. Neurobiology of Glycoconjugates. Plenum Press, New York, 1989; 453 pp.
- Norton, W. T; Poduslo, S. E., Myelination in rat brain: Changes in myelin composition during brain maturation. J. Neurochem. 1973, 21 759–773.
- Coetzee, T; Suzuki, K; Popko, B., New perspectives on the function of myelin galactolipids. Trends Neurosci. 1998, 21 126–130.
- Stults, C. L. M; Sweeley, C. C; Macher, B. A., Glycosphingolipids: Structure, biological source, and properties. Methods Enzymol. 1989, 179 167–214.
- Tettamanti, G; Bonali, F; Marchesini, S; Zambotti, V., A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 1973, 296 160–170.
- Svennerholm, L; Fredman, P., A procedure for the quantitative isolation of brain gangliosides. Biochim. Biophys. Acta 1980, 617 97–109.
- Margolis, R. K; Preti, C; Lai, D; Margolis, R. U., Developmental changes in brain glycoproteins. Brain Res. 1976, 112 363–369.
- Margolis, R. U; Margolis, R. K; Chang, L. B; Preti, C., Glycosaminoglycans of brain during development. Biochemistry 1975, 14 85–88.
- De Haas, C. G; Lopes-Cardozo, M., Hydroxy- and non-hydroxy-galactolipids in developing rat CNS. Intl J. Dev. Neurosci. 1995, 13 447–454.
- Bosio, A; Binczek, E; Haupt, W. F; Stoffel, W., Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice. J. Neurochem. 1998, 70 308–315.
- Nakakuma, H; Arai, M; Kawaguchi, T; Horikawa, K; Hidaka, M; Sakamoto, K; Iwamori, M; Nagai, Y; Takatsuki, K., Monoclonal antibody to galactosylceramide: discrimination of structural difference in the ceramide moiety. FEBS Lett. 1989, 258 230–232.
- Coetzee, T; Fujita, N; Dupree, J; Shi, R; Blight, A; Suzuki, K; Popko, B., Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 1996, 86 209–219.
- Bosio, A; Binczek, E; Stoffel, W., Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl Acad. Sci. U.S.A. 1996, 93 13280–13285.
- Lemke, G., Myelin and myelination. In An Introduction to Molecular Neurobiology; Z. Hall, Ed.; Sinauer: Sunderland, MA, 1992; pp. 281–309.
- Dupree, J. L; Coetzee, T; Blight, A; Suzuki, K; Popko, B., Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J. Neurosci. 1998, 18 1642–1649.
-
Coetzee, T;
Dupree, J. L;
Popko, B.,
Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
J. Neurosci. Res.
1998,
54
613–622.
10.1002/(SICI)1097-4547(19981201)54:5<613::AID-JNR6>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- Kotani, M; Tai, T., An immunohistochemical technique with a series of monoclonal antibodies to gangliosides: their differential distribution in the rat cerebellum. Brain Res. Brain Res. Protoc. 1997, 1 152–156.
- Yu, R. K; Macala, L. J; Taki, T; Weinfeld, H. M; Yu, F. S., Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 1988, 50 1825–1829.
- Schwarz, A; Futerman, A. H., The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta 1996, 1286 247–267.
- Svennerholm, L., Gangliosides and synaptic transmission. Adv. Exp. Med. Biol. 1980, 125 533–544.
- van Echten, G; Sandhoff, K., Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem. 1993, 268 5341–5344.
- Takamiya, K; Yamamoto, A; Furukawa, K; Yamashiro, S; Shin, M; Okada, M; Fukumoto, S; Haraguchi, M; Takeda, N; Fujimura, K; Sakae, M; Kishikawa, M; Shiku, H; Aizawa, S., Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl Acad. Sci. U.S.A. 1996, 93 10662–10667.
- Liu, Y; Wada, R; Kawai, H; Sango, K; Deng, C; Tai, T; McDonald, M. P; Araujo, K; Crawley, J. N; Bierfreund, U; Sandhoff, K; Suzuki, K; Proia, R. L., A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 1999, 103 497–505.
- Sheikh, K. A; Sun, J; Liu, Y; Kawai, H; Crawford, T. O; Proia, R. L; Griffin, J. W; Schnaar, R. L., Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 7532–7537.
- Hakomori, S., Bifunctional role of glycosphingolipids: Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 1990, 265 18713–18716.
- Schnaar, R. L., Glycosphingolipids in cell surface recognition. Glycobiology 1991, 1 477–485.
- Simons, K; Ikonen, E., Functional rafts in cell membranes. Nature 1997, 387 569–572.
- Kasahara, K; Watanabe, Y; Yamamoto, T; Sanai, Y., Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae- like domains. J. Biol. Chem. 1997, 272 29947–29953.
- Igarashi, Y; Nojiri, H; Hanai, N; Hakomori, S., Gangliosides that modulate membrane protein function. Methods Enzymol. 1989, 179 521–541.
- Trapp, B. D., Myelin-associated glycoprotein. Location and potential functions. Ann. N. Y. Acad. Sci. 1990, 605 29–43.
- Yang, L. J. S; Zeller, C. B; Shaper, N. L; Kiso, M; Hasegawa, A; Shapiro, R. E; Schnaar, R. L., Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl Acad. Sci. U.S.A. 1996, 93 814–818.
- Collins, B. E; Kiso, M; Hasegawa, A; Tropak, M. B; Roder, J. C; Crocker, P. R; Schnaar, R. L., Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J. Biol. Chem. 1997, 272 16889–16895.
- Rogers, T. B; Snyder, S. H., High affinity binding of tetanus toxin to mammalian brain membranes. J. Biol. Chem. 1981, 256 2402–2407.
- Shapiro, R. E; Specht, C. D; Collins, B. E; Woods, A. S; Cotter, R. J; Schnaar, R. L., Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand. J. Biol. Chem. 1997, 272 30380–30386.
- Griffin, J. W; Li, C. Y; Ho, T. W; Tian, M; Gao, C. Y; Xue, P; Mishu, B; Cornblath, D. R; Macko, C; McKhann, G. M; Asbury, A. K., Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann. Neurol. 1996, 39 17–28.
- Sheikh, K. A; Nachamkin, I; Ho, T. W; Willison, H. J; Veitch, J; Ung, H; Nicholson, M; Li, C. Y; Wu, H. S; Shen, B. Q; Cornblath, D. R; Asbury, A. K; McKhann, G. M; Griffin, J. W., Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology 1998, 51 371–378.
- Yuki, N; Taki, T; Inagaki, F; Kasama, T; Takahashi, M; Saito, K; Handa, S; Miyatake, T., A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 1993, 178 1771–1775.
- Quarles, R. H; Ilyas, A. A; Willison, H. J., Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chem. Phys. Lipids 1986, 42 235–248.
- Quarles, R. H., Myelin-associated glycoprotein in demyelinating disorders. Crit. Rev. Neurobiol. 1989, 5 1–28.
- Ariga, T; Kohriyama, T; Freddo, L; Latov, N; Saito, M; Kon, K; Ando, S; Suzuki, M; Hemling, M. E; Rinehart, K. L; Kusunoki, S; Yu, R. K., Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy. J. Biol. Chem. 1987, 262 848–853.
- Needham, L. K; Schnaar, R. L., Carbohydrate recognition in the peripheral nervous system: A calcium-dependent membrane binding site for HNK-1 reactive glycolipids potentially involved in Schwann cell adhesion. J. Cell Biol. 1993, 121 397–408.
- Nair, S. M; Jungalwala, F. B., Characterization of a sulfoglucuronyl carbohydrate binding protein in the developing nervous system. J. Neurochem. 1997, 68 1286–1297.
- Svennerholm, L; Boström, K; Fredman, P; Jungbjer, B; Lekman, A; Månsson, J.-E; Rynmark, B.-M., Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim. Biophys. Acta 1994, 1214 115–123.
- Jones, R. T; Walker, J. H; Richardson, P. J; Fox, G. Q; Whittaker, V. P., Immunohistochemical localization of cholinergic nerve terminals. Cell Tissue Res. 1981, 218 355–373.
- Hirabayashi, Y; Nakao, T; Irie, F; Whittaker, V. P; Kon, K; Ando, S., Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain. J. Biol. Chem. 1992, 267 12973–12978.
- Ando, S; Hirabayashi, Y; Kon, K; Inagaki, F; Tate, S; Whittaker, V. P., A trisialoganglioside containing a sialyl α2–6 N-acetylgalactosamine residue is a cholinergic-specific antigen, Chol-1α-a. J. Biochem. 1992, 111 287–290.
- Rutishauser, U; Acheson, A; Hall, A. K; Mann, D. M; Sunshine, J., The neural cell adhesion molecule(NCAM) as a regulator of cell-cell interactions. Science 1988, 240 53–57.
- Troy, F. A., Polysialylation: from bacteria to brains. Glycobiology. 1992, 2 5–23.
- Rutishauser, U; Landmesser, L., Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell–cell interactions. Trends Neurosci. 1996, 19 422–427.
- Schachner, M; Martini, R., Glycans and the modulation of neural-recognition molecule function. Trends Neurosci. 1995, 18 183–191.
- Martini, R; Zielasek, J; Toyka, K. V; Giese, K. P; Schachner, M., Protein zero(PO)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 1995, 11 281–286.
- Voshol, H.; van Zuylen, C. W; Orberger, G; Vliegenthart, J. F; Schachner, M., Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein P0. J. Biol. Chem. 1996, 271 22957–22960.
-
Margolis, R. K;
Margolis, R. U.,
Structure and localization of glycoproteins and proteoglycans.
In Neurobiology of Glycoconjugates;
R. U. Margolis,
R. K. Margolis, Eds.;
Plenum Press: New York,
1989;
pp. 85–126.
10.1007/978-1-4757-5955-6_3 Google Scholar
- Ruoslahti, E., Brain extracellular matrix. Glycobiology. 1996, 6 489–492.
- Sharon, N; Lis, H., Lectins–proteins with a sweet tooth: functions in cell recognition. Essays Biochem. 1995, 30: 59–75.
- Weis, W. I; Drickamer, K., Structural basis of lectin-carbohydrate recognition. Annu. Rev. Biochem. 1996, 65 441–473.
- Iwabuchi, K; Yamamura, S; Prinetti, A; Handa, K; Hakomori, S., GM3-enriched micro-domain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J. Biol. Chem. 1998, 273 9130–9138.
- Schwab, M. E; Kapfhammer, J. P; Bandtlow, C. E., Inhibitors of neurite growth. Annu. Rev. Neurosci. 1993, 16 565–595.
- Trapp, B. D; Andrews, S. B; Cootauco, C; Quarles, R., The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J. Cell Biol. 1989, 109 2417–2426.
- Sadoul, R; Fahrig, T; Bartsch, U; Schachner, M., Binding properties of liposomes containing the myelin-associated glycoprotein MAG to neural cell cultures. J. Neurosci. Res. 1990, 25 1–13.
- Johnson, P. W; Abramow-Newerly, W; Seilheimer, B; Sadoul, R; Tropak, M. B; Arquint, M; Dunn, R. J; Schachner, M; Roder, J. C., Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron 1989, 3 377–385.
- Yin, X; Crawford, T. O; Griffin, J. W; Tu, P; Lee, V. Y; Li, C; Roder, J; Trapp, B. D., Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 1998, 18 1953–1962.
- Fruttiger, M; Montag, D; Schachner, M; Martini, R., Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 1995, 7 511–515.
-
Lassmann, H;
Bartsch, U;
Montag, D;
Schachner, M.,
Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency.
Glia
1997,
19
104–110.
10.1002/(SICI)1098-1136(199702)19:2<104::AID-GLIA2>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- Bartsch, S; Montag, D; Schachner, M; Bartsch, U., Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein(MAG). Brain Res. 1997, 762 231–234.
- Schäfer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R., Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron 1996, 16 1107–1113.
- Kelm, S; Pelz, A; Schauer, R; Filbin, M. T; Song, T.; de Bellard, M. E; Schnaar, R. L; Mahoney, J. A; Hartnell, A; Bradfield, P; Crocker, P. R., Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 1994, 4 965–972.
- Crocker, P. R; Clark, E. A; Filbin, M; Gordon, S; Jones, Y; Kehrl, J. H; Kelm, S; Le Douarin, N; Powell, L; Roder, J; Schnaar, R. L; Sgroi, D. C; Stamenkovic, K; Schauer, R; Schachner, M.; van den Berg, T. K.; van der Merwe, P. A; Watt, S. M; Varki, A., Siglecs: a family of sialic-acid binding lectins. Glycobiology 1998, 8 v.
- Collins, B. E; Yang, L. J. S; Mukhopadhyay, G; Filbin, M. T; Kiso, M; Hasegawa, A; Schnaar, R. L., Sialic acid specificity of myelin-associated glycoprotein binding. J. Biol. Chem. 1997, 272 1248–1255.
- DeBellard, M.-E; Tang, S; Mukhopadhyay, G; Shen, Y.-J; Filbin, M. T., Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sia-loglycoprotein. Mol. Cell. Neurosci. 1996, 7 89–101.
- Drickamer, K., Evolution of Ca2+—dependent animal lectins. Prog. Nucleic Acid Res. 1993, 45 207–232.
- Miura, R; Aspberg, A; Ethell, I. M; Hagihara, K; Schnaar, R. L; Ruoslahti, E; Yamaguchi, Y., The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J. Biol. Chem. 1999, 274 11431–11438.
- Nair, S. M; Zhao, Z; Chou, D. K; Tobet, S. A; Jungalwala, F. B., Expression of HNK-1 carbohydrate and its binding protein, SBP-1, in apposing cell surfaces in cerebral cortex and cerebellum. Neuroscience 1998, 85 759–771.
- Barondes, S. H; Cooper, D. N; Gitt, M. A; Leffler, H. Galectins, Structure and function of a large family of animal lectins. J. Biol. Chem. 1994, 269 20807–20810.
- Hynes, M. A; Gitt, M; Barondes, S. H; Jessell, T. M; Buck, L. B., Selective expression of an endogenous lactose-binding lectin gene in subsets of central and peripheral neurons. J. Neurosci. 1990, 10 1004–1013.
- Finne, J., Structure of the O-glycosidically linked carbohydrate units of rat brain glycoproteins. Biochim. Biophys. Acta 1975, 412 317–325.
- Svennerholm, L., Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog. Brain Res. 1994, 101 xi–xiv.
- Ichikawa, S; Sakiyama, H; Suzuki, G; Hidari, K. I; Hirabayashi, Y., Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl Acad. Sci. U.S.A. 1996, 93 4638–4643.
- Nomura, T; Takizawa, M; Aoki, J; Arai, H; Inoue, K; Wakisaka, E; Yoshizuka, N; Imokawa, G; Dohmae, N; Takio, K; Hattori, M; Matsuo, N., Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain. J. Biol. Chem. 1998, 273 13570–13577.
- Ishii, A; Ohta, M; Watanabe, Y; Matsuda, K; Ishiyama, K; Sakoe, K; Nakamura, M; Inokuchi, J; Sanai, Y; Saito, M., Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J. Biol. Chem. 1998, 273 31652–31655.
- Nara, K; Watanabe, Y; Maruyama, K; Kasahara, K; Nagai, Y; Sanai, Y., Expression cloning of a CMP-NeuAc:NeuAcα 2- 3Galβ1–4Glcβ1–1′Cer α2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc. Natl Acad. Sci. U.S.A. 1994, 91 7952–7956.
- Nagata, Y; Yamashiro, S; Yodoi, J; Lloyd, K. O; Shiku, H; Furukawa, K., Expression cloning of β1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J. Biol. Chem. 1992, 267 12082–12089.
- Miyazaki, H; Fukumoto, S; Okada, M; Hasegawa, T; Furukawa, K., Expression cloning of rat cDNA encoding UDP-galactose:GD2 beta1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1. J. Biol. Chem. 1997, 272 24794–24799.
- Lee, Y. C; Kojima, N; Wada, E; Kurosawa, N; Nakaoka, T; Hamamoto, T; Tsuji, S., Cloning and expression of cDNA for a new type of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase. J. Biol. Chem. 1994, 269 10028–10033.
